453 related articles for article (PubMed ID: 25042676)
1. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population.
Kweon OJ; Choi JH; Park SK; Park AJ
J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S
J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.
Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U
Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134
[TBL] [Abstract][Full Text] [Related]
5. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial.
Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L;
Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis.
Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A
J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331
[TBL] [Abstract][Full Text] [Related]
7. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis.
Vodnik T; Kaljevic G; Tadic T; Majkic-Singh N
Clin Chem Lab Med; 2013 Oct; 51(10):2053-62. PubMed ID: 23740685
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
[TBL] [Abstract][Full Text] [Related]
9. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis.
Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S
Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032
[TBL] [Abstract][Full Text] [Related]
10. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy.
Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J
Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.
Endo S; Suzuki Y; Takahashi G; Shozushima T; Ishikura H; Murai A; Nishida T; Irie Y; Miura M; Iguchi H; Fukui Y; Tanaka K; Nojima T; Okamura Y
J Infect Chemother; 2012 Dec; 18(6):891-7. PubMed ID: 22692596
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
13. Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.
Pugni L; Pietrasanta C; Milani S; Vener C; Ronchi A; Falbo M; Arghittu M; Mosca F
PLoS One; 2015; 10(12):e0146020. PubMed ID: 26720209
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of presepsin as diagnostic and prognostic marker of sepsis in daily clinical practice.
Jereb M; Mavric M; Skvarc M; Drobnic A; Dolenc S; Strunjas NP; Luksic B; Kmet NG
J Infect Dev Ctries; 2019 Nov; 13(11):1038-1044. PubMed ID: 32087076
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnostic value of Presepsin in sepsis: a prospective study on a population with suspected sepsis in fever clinics].
Zong X; Liu Y; Gu L; Chen X; Yang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):340-344. PubMed ID: 38813625
[TBL] [Abstract][Full Text] [Related]
16. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.
Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V
J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884
[TBL] [Abstract][Full Text] [Related]
17. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis.
Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M
Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis.
Bellos I; Fitrou G; Pergialiotis V; Thomakos N; Perrea DN; Daskalakis G
Eur J Pediatr; 2018 May; 177(5):625-632. PubMed ID: 29476345
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department.
de Guadiana Romualdo LG; Torrella PE; Acebes SR; Otón MDA; Sánchez RJ; Holgado AH; Santos EJ; Freire AO
Clin Chim Acta; 2017 Jan; 464():6-11. PubMed ID: 27823951
[TBL] [Abstract][Full Text] [Related]
20. Presepsin as a predictor of septic shock in patients with urinary tract infection.
Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K
BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]